English
Français
Our Company
About Us
Leadership
Board of Directors
Scientific Advisors
Our Science
Our Technology
Scientific Publications
Pipeline
LYS-SAF302
LYS-GM101
Discovery
For Patients
Clinical Trials
LYS-SAF302 Clinical Trial
LYS-GM101 Clinical Trial
GM1 Natural History Study
Diseases
MPS IIIA
GM1 Gangliosidosis
Fragile X Syndrome
Gaucher & Parkinson’s
Resources
Gene Therapy
Patient Organizations
Investors & Media
Investor Overview
Stock Information
Regulated Information
Annual Meetings
News
Press Releases
In the Media
Events
Corporate Presentation
In the Media
Karen Pignet-Aiach: “On m’a dit:“il n’y a rien à faire.”
Ça m’a motivée “
L'Express - 6 November 2019
Karen Pignet-Aiach: “Lysogene Est Financee Au-Dela De 2021”
Le Revenue - 15 March 2019
Pour L’amour D’ornella: Le Combat D’une Mere Pour Sauver Sa Fille
Paris Match - 18 February 2019
Le Combat D’une Mere Pour Sauver Des Milliers D’enfants
Télé Matin - 8 February 2019
Vivre Avec La Maladie De Son Enfant Au Quotidien
Je t'aime ect - 4 February 2019
Entretien De Karen Aiach Pour Konbini
Konbini News - 22 January 2019
Our Company
About Us
Leadership
Board of Directors
Scientific Advisors
Our Science
Our Technology
Scientific Publications
Pipeline
LYS-SAF302
LYS-GM101
Discovery
For Patients
Clinical Trials
LYS-SAF302 Clinical Trial
LYS-GM101 Clinical Trial
GM1 Natural History Study
Diseases
MPS IIIA
GM1 Gangliosidosis
Fragile X Syndrome
Gaucher & Parkinson’s
Resources
Gene Therapy
Patient Organizations
Investors & Media
Investor Overview
Stock Information
Regulated Information
Annual Meetings
News
Press Releases
In the Media
Events
Corporate Presentation
Our Company
About Us
Leadership
Board of Directors
Scientific Advisors
Our Science
Our Technology
Scientific Publications
Pipeline
LYS-SAF302
LYS-GM101
Discovery
For Patients
Clinical Trials
LYS-SAF302 Clinical Trial
LYS-GM101 Clinical Trial
GM1 Natural History Study
Diseases
MPS IIIA
GM1 Gangliosidosis
Fragile X Syndrome
Gaucher & Parkinson’s
Resources
Gene Therapy
Patient Organizations
Investors & Media
Investor Overview
Stock Information
Regulated Information
Annual Meetings
News
Press Releases
In the Media
Events
Corporate Presentation
Start Typing
English
Français
We use cookies to ensure that we give you the best experience on our website. By accepting, you are agreeing to our use of cookies per our privacy policy.
Accept
Decline
Privacy policy